Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Y-mAbs Therapeutics, Inc. (YMAB)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Mar-31-20Dec-31-19Mar-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K8-K10-K8-K10-K10-KS-1/A
Net income  -55.3-119.3-26.2-81.0-15.9-43.3-19.20.0
Depreciation and amortization  0.80.4 0.2 0.0  
Stock-based compensation  19.316.1 4.7 2.00.60.3
Change in working capital   [+]12.228.0 35.4 14.87.10.5
Other operating activities  -79.6-16.4 -32.7 -14.8-4.4-11.9
Cash from operations  -102.6-91.2 -73.5 -41.2-15.9-11.2
   
Capital expenditures   [+]-0.7-0.2 -2.0 -0.20.00.0
Purchases of intangible assets  -0.3       
Other cash from investing   -2.6      
Cash from investing  61.0-2.8 -2.0 -0.20.00.0
   
Issuance of common stock, net  107.7  134.7 99.889.819.0
Option exercises  0.62.0      
Other cash from financing  1.24.0   -1.0-0.3 
Cash from financing  108.32.0 134.7 98.889.619.0
   
Free cash flow  -103.2-91.4 -75.5 -41.5-15.9-11.2
        Per share (diluted)  ($2.39)($2.28) ($2.14) ($1.44)($0.82)($792.62)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy